Prevalence of muscle atrophy in pediatric patients during ICU hospitalization

Jéssica K De Oliveira1,2,3, Taila C Piva4, Renata S Ferrari4

  • 1Graduate Program in Pediatrics, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil. jessicaknisspell@gmail.com.

PubMed

Insights

Critically ill children experienced significant muscle loss, particularly in the second week of mechanical ventilation. Ultrasound monitoring revealed muscle atrophy in over 30% of patients, highlighting its importance in pediatric intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Diagnostic imaging
  • Muscle physiology

Background:

  • Ultrasound (US) is a valuable bedside tool for monitoring muscle mass in critical patients.
  • Previous studies validated US for muscle atrophy detection in adults, with limited pediatric data.

Purpose of the Study:

  • To evaluate muscle thickness and atrophy prevalence in critically ill children using ultrasound.
  • To assess biceps brachii/brachialis (BB) and quadriceps femoris (QF) muscle changes during pediatric intensive care unit (PICU) hospitalization.

Main Methods:

  • Prospective longitudinal study in a tertiary hospital's PICU.
  • Ultrasound measurements of BB and QF thickness in ventilated children (1 month-12 years) at 24h, 72h, and weekly.
  • Muscle atrophy defined as >10% decrease in thickness.

Main Results:

  • Significant reduction in BB thickness from week 1 to 2 (p=0.009) and QF from 24h to week 2 (p=0.013).
  • Prevalence of muscle atrophy was 59.3% between 24h and 2 weeks.
  • At 2 weeks PICU hospitalization, atrophy prevalence was 30.8% in BB and 46.2% in QF.

Conclusions:

  • Ultrasound effectively evaluates muscle thickness in critically ill children.
  • Muscle atrophy is prevalent in critically ill children, especially during the second week of PICU stay.
  • Regular muscle monitoring via ultrasound is crucial for identifying muscle loss in this population.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
905
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
186
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
348
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.0K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
163